Список литературы.

Поставить закладку

Д.А. Сычев. Полипрагмазия в клинической практике: проблема и решения / учеб.пособие. – СПб.: ЦОП «Профессия», 2016 – 224 с., ил. [DA Sychev. Polypragmazia in Clinical Practice: problem and - SPb-COP-«Professija»-2016–224 p., il. (In Russ.).]
Mar Martin-Pérez, Ana López de Andrés, Valentín Hernández-Barrera, Rodrigo Jiménez- García, Isabel Jiménez-Trujillo, Domingo Palacios-Ceña, Pilar Carrasco-Garrido, Prevalencia de polifarmacia en la población mayor de 65 años en España: análisis de las Encuestas Nacionales de Salud 2006 y 2011/12, Revista Española de Geriatría y Gerontología, Volume 52, Issue 1,2017, Pages 2-8. [Prevalence of polypharmacy among the population older than 65 years in Spain: Analysis of the 2006 and 2011/12 National Health Surveys]. [Article in Spanish]. Rev Esp Geriatr Gerontol. 2017;52(1):2-8. https://doi.org/10.1016/j.regg.2016.07.006
Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc. 2015;16(6):535.e1-12. https://doi.org/10.1016/j.jamda.2015.03.003.
Boeker ЕВ, Ram К, Klopotowska JE, de Boer M, Creus MT, de Andrés AL, Sakuma M, Morimoto T, Boermeester MA, Dijkgraaf MGW. An individual patient data meta-analysis on factors associated with adverse drug events in surgical and non-surgical inpatients. Br J Clin Pharmacol. 2015;79(4): 548–557. https://doi.org/10.1111/bcp.12504

Jetha S. Polypharmacy, the Elderly, and Deprescribing. Consult Pharm. 2015;30(9):527-32. https://doi.org/10.4140/TCP.n.2015.527
Остроумова О.Д. , Голобородова И.В., Исаев Р.И., Переверзев А.П., Антипсихотики: особенности нежелательных побочных реакций у лиц пожилого и старческого возраста. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(2): 105-117. [Ostroumova OD, Goloborodova IV, Isaev-RI, Pereverzev AP. Antipsychotic: Peculiarities of undesirable adverse reactions in elderly and senile age groups. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2): 105-117(in Russian)]. DOI: 10.17116/jnevro2019119021105
Деменция. ВОЗ. 2017 г. https://www.who.int/ru/news-room/fact-sheets/detail/dementia. Ссылка активна на 29.09.2019.
Bohlken J, Booker A, Kostev K. [High Prevalence of Antipsychotic Medication Use in Dementia Patients in German Neuropsychiatric Practices]. Fortschr Neurol Psychiatr. 2017;85(6):345-351. https://doi.org/10.1055/s-0043-104931.
Pringsheim T, Gardner DM. Dispensed prescriptions for quetiapine and other second- generation antipsychotics in Canada from 2005 to 2012: a descriptive study. CMAJ Open 2014;2(4):E225-32. https://doi.org/10.9778/cmajo.20140009
National Audit of Dementia care in general hospitals 2012–13 Second round audit report and update Royal College of Psychiatrists. 2013 https://www.hqip.org.uk/resource/national-audit-of- dementia-care-in-general-hospitals-2012-13-second-round-audit-report-and-update/ Ссылка активна на 29.09.2019.
Gallagher P, Curtin D, de Siún A, O'Shea E, Kennelly S, O'Neill D, Timmons S. Antipsychotic prescription amongst hospitalized patients with dementia. QJM. 2016;109(9):589– 593. https://doi.org/10.1093/qjmed/hcw023
Liperoti R, Sganga F, Landi F, Topinkova E, Denkinger MD, van der Roest HG, Foebel AD, Finne-Soveri H, Bernabei R, Onder G. Antipsychotic drug interactions and mortality among nursing home residents with cognitive impairment. J Clin Psychiatry. 2017;78(1):e76-e82. https://doi.org/10.4088/jcp.15m10303
Pariente A, Fourrier-Reglat A, Ducruet T, Farrington P, Béland SG, Dartigues JF, Moore N, Moride Y. Antipsychotic use and myocardial infarction in older patients with treated dementia. Arch Intern Med. 2012;172(8):648–653. https://doi.org//10.1001/archinternmed.2012.28
Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000;355(9209):1048-1052. https://doi.org//10.1016/S0140-6736(00)02035-3
Kleijer BC, van Marum RJ, Egberts AC, Jansen PA, Knol W, Heerdink ER.. Risk of cerebrovascular events in elderly users of antipsychotics. J Psychopharmacol. 2009;23(8):909– 914. https://doi.org//10.1177/0269881108093583
Nanasawa H, Sako A, Mitsutsuka T, Nonogaki K, Kondo T, Mishima S, Uju Y, Ito T, Enomoto T, Hayakawa T, Yanai H. Development of diabetes mellitus associated with quetiapine: A case series. Medicine (Baltimore). 2017;96(3):e5900. https://doi.org/10.1097/md.0000000000005900
Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ 3rd. Psychotropic drug use and the risk of hip fracture. N Engl J Med. 1987;316 (7):363-369. https://doi.org//10.1056/NEJM198702123160702
Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int. 2006;17(6):807–816. https://doi.org//10.1007/s00198-005-0065-y
Pouwels S, van Staa TP, Egberts AC, Leufkens HGM, Cooper C, de Vries F. Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study. Osteoporos Int. 2009;20(9):1499–1506. https://doi.org//10.1007/s00198-008-0826-5
Sоrensen HJ, Jensen SO, Nielsen J. Schizophrenia, antipsychotics and risk of hip fracture: a population-based analysis. Eur Neuropsychopharmacol. 2013;23(8):872–878. https://doi.org//10.1016/j.euroneuro.2013.04.002
Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman-Wilms L, Rojas- Fernandez C, Sinha S, Thompson W, Welch V, Wiens A. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline. Can Fam Physician. 2018;64(1):17-27.
Ткачева О.Н., Остроумова О.Д., Краснов Г.С., Исаев Р.И., Котовская Ю.В. Доказательная база снижения количества и доз антипсихотиков у пациентов пожилого и старческого возраста. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(5):162-172. [Tkacheva ON, Ostroumova OD, Krasnov GS, Isaev RI, Kotovskaya YuV. Evidence database for deprescribing of antipsychotic drugs in elderly and senile patients. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2019;119(5):162-172. (In Russ.).]. https://doi.org/10.17116/jnevro2019119051162
Van Leeuwen E, Petrovic M, van Driel ML, De Sutter A, Vander Stichele R, Declercq T, Christiaens T. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2018;3:CD007726. https://doi.org//10.1002/14651858 CD007726.pub3. [Epub ahead of print]
Thompson W, Quay T, Tang J, Bjerre LM, Farrell B. Atypical antipsychotics for insomnia: a systematic review and meta-analysis. PROSPERO 2015;CRD42015017748. Available from: www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42015017748. Accessed 2017 Nov 20.
Thompson W, Quay T, Rojas-Fernandez C, Farrell B, Bjerre LM. Atypical antipsychotics for insomnia:a systematic review. Sleep Med 2016;22:13-7. doi: 10.1016/j.sleep.2016.04.003.
Ballard C, Thomas A, Fossey J, Lee L, Jacoby R, Lana MM, Bannister C, McShane R, Swann A, Juszczak E, O'Brien JT. A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the Neuropsychiatric Inventory median cut- off is a predictor of clinical outcome. Journal of Clinical Psychiatry 2004;65(1):114–9. https://doi.org/10.4088/jcp.v65n0120
Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R, Kossakowski K, Yu L-M, Juszczak E, and on behalf of the Investigators DART AD. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Medicine 2008;5(4):e76. ISRCTN33368770. https://doi.org/10.1371/journal.pmed.0050076
Ruths S, Straand J, Nygaard HA, Aarsland D. Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study—the Bergen District Nursing Home Study (BEDNURS). Int J Geriatr Psychiatry 2008;23(9):889-95. doi: 10.1002/gps.1998.
van Reekum R, Clarke D, Conn D, Herrmann N, Eryavec G, Cohen T, Ostrander L. A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia. International Psychogeriatrics 2002;14(2): 197–210. https://doi.org/10.1017/s1041610202008396
Остроумова О.Д, Исаев Р.И., Переверзев А.П. Лекарственно-индуцированная инсомния у пациентов пожилого и старческого возраста. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(8):142–52.[Ostroumova O.D., Isaev R.I., Pereverzev A.P. Drug-induced insomnia in old and very old patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8):142-52. (In Russ.)]. DOI: 10.17116/jnevro2019119081142
Corbett A, Husebo B, Malcangio M, Staniland A, Cohen-Mansfield J, Aarsland D, Ballard C. Assessment and treatment of pain in people with dementia. Nat Rev Neurol 2012;8(5):264-74. Erratum in: Nat Rev Neurol 2013;9(7):358. doi: 10.1038/nrneurol.2012.53.
Schofield P. The Assessment of Pain in Older People: UK National Guidelines. Age and Ageing 2018; 47 (Issue suppl_1):i1–i22. https://doi.org/10.1093/ageing/afx192
Hort J, O’Brien JT, Gainotti G, Pirttila T, Popescu BO, Rektorova I, Sorbi S, Scheltens P; EFNS Scientist Panel on Dementia. EFNS guidelines for the diagnosis and management of Alzheimer’s disease. Eur J Neurol 2010;17(10):1236-48. doi: 10.1111/j.1468- 1331.2010.03040.x.
Переверзев А.П., Остроумова О.Д., Исаев Р.И., Ткачева О.Н., Котовская Ю.В. Лекарственно-индуцированный делирий у пациентов пожилого и старческого возраста. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(7): 120-127. [Pereverzev AP, Ostroumova OD, Isaev RI, Tkacheva ON, Kotovskaya YuV. Drug-induced delirium in elderly and senile patients. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2019;119(7):120-127. (In Russ.).]. DOI: 10.17116/jnevro2019119071120
Rabins RV, Rovner BW, Rummans T, Schneider LS, Tariot PN. Guideline watch (October 2014): practice guideline for the treatment of patients with Alzheimer’s disease and other dementias. Arlington, VA: The American Psychiatric Association; 2014.
Gauthier S, Patterson C, Chertkow H, Gordon M, Herrmann N, Rockwood K, et al. Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4). Can Geriatr J 2012;15(4):120-6.
Best Practice Advocacy Centre New Zealand. Antipsychotics in dementia: best practice guide. Dunedin,NZ: Best Practice Advocacy Centre New Zealand; 2009.